» Articles » PMID: 25202106

Elderly Women Above Screening Age Diagnosed with Cervical Cancer Have a Worse Prognosis

Overview
Journal Anticancer Res
Specialty Oncology
Date 2014 Sep 10
PMID 25202106
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To analyze the cervical screening history in women with cervical cancer and their outcome.

Design: All women diagnosed with cervical cancer between January 2009 and December 2010 in the South Sweden region were included in the audit.

Materials And Methods: Cervical cancer was registered in 165 women in 2009 and 2010. Their screening history was analyzed, and was classified as normal or imperfect. The method of discovering the cancer was either by symptoms or by screening. The main outcome measured was overall survival in cervical cancer related to cervical screening history.

Results: Women above 65 years of age were more frequently diagnosed with advanced-stage disease (The International Federation of Gynecology and Obstetrics II-IV) (n=36 out of 43; 84%) compared to women below 65 years of age (n=35 out of 122; 29%) (p<0.001). All patients diagnosed by the cervical screening program were still alive (30/30) at the median follow-up time (36 months), showing better overall survival compared to women below screening age in whom cancer was discovered due to symptoms (68/98; p<0.001). Cox proportional hazards model showed that women beyond screening age (>65 years old) with normal screening history had a worse prognosis, with a hazard ratio of 4.8 (95% confidence interval=1.9-12.1, p=0.001), and women (>65 years old) who had not followed the screening program had a hazard ratio of 5.9 (95% confidence interval I 2.4-14.6, p<0.001), compared to women under 65 years old who had followed the screening program.

Conclusion: Cervical cancer in women above the age of 65 years is discovered at advanced stages of the disease and their prognosis is poor.

Citing Articles

Prevalence of human papillomavirus and cervical lesions among elderly women: an unignored challenge to cervical cancer prevention.

Huiyun J, Yuebo Y, Xiaomao L Ann Med. 2024; 56(1):2404548.

PMID: 39298375 PMC: 11413955. DOI: 10.1080/07853890.2024.2404548.


Improving diagnostic of cervical dysplasia among postmenopausal women aged ≥50 years using local vaginal oestrogen treatment prior to colposcopy: study protocol for a multicentre randomised controlled trial (the IDEAL study).

Bertelsen V, Tranberg M, Petersen L, Booth B, Bor P BMJ Open. 2024; 14(6):e082833.

PMID: 38910002 PMC: 11328618. DOI: 10.1136/bmjopen-2023-082833.


Evaluation of the diagnostic performance of colposcopy in the detection of cervical high-grade squamous intraepithelial lesions among women with transformation zone type 3.

Li X, Zhao Y, Xiang F, Zhang X, Chen Z, Zhang M BMC Cancer. 2024; 24(1):381.

PMID: 38528547 PMC: 10964607. DOI: 10.1186/s12885-024-12156-2.


History of HPV in HPV-positive elderly women.

Hermansson R, Lillsunde-Larsson G, Helenius G, Karlsson M, Kaliff M, Olovsson M Eur J Obstet Gynecol Reprod Biol X. 2024; 22:100297.

PMID: 38496379 PMC: 10944087. DOI: 10.1016/j.eurox.2024.100297.


Older women's perceptions of HPV self-sampling and HPV-sampling performed by a midwife - a phenomenographic study.

Nyman M, Larsson G, Blomberg K, Schroder A BMC Public Health. 2024; 24(1):211.

PMID: 38233805 PMC: 10795362. DOI: 10.1186/s12889-024-17723-7.